17 Patents
- US125839392026Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US125707642026Anti-muc16 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind MUC16 and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US125457352026Anti-met Antibodies, Bispecific Antigen Binding Molecules That Bind Met, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - 0 cites
- 0 cites
- US123782582025Biologically Active Molecules, Conjugates Thereof, and Therapeutic Uses
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122972072025Maytansinoid Derivatives, Conjugates Thereof, and Methods of Use
Regeneron Pharmaceuticals, Inc.
0 cites - US119589102024Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US116335012023Anti-steap2 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind STEAP2 and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US115966352023Pharmaceutical Compositions Comprising Macrolide Diastereomers, Methods of Their Synthesis and Therapeutic Uses
REGENERON PHARMACEUTICALS, Inc.
0 cites